{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:27:40Z","timestamp":1773149260311,"version":"3.50.1"},"reference-count":41,"publisher":"BMJ","issue":"Suppl 4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,8,21]]},"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>Antimicrobial resistance (AMR) in<jats:italic>Neisseria gonorrhoeae<\/jats:italic>has emerged for essentially all antimicrobials following their introduction into clinical practice. During the latest decade, susceptibility to the last remaining options for antimicrobial monotherapy, the extended-spectrum cephalosporins (ESC), has markedly decreased internationally and treatment failures with these ESCs have been verified. In response to this developing situation, WHO and the European Centre for Disease Prevention and Control (ECDC) have published global and region-specific response plans, respectively. One main component of these action\/response plans is to enhance the surveillance of AMR and treatment failures. This paper describes the perspectives from the diverse WHO European Region (53 countries), including the independent countries of the former Soviet Union, regarding gonococcal AMR surveillance networks. The WHO European Region has a high prevalence of resistance to all previously recommended antimicrobials, and most of the first strictly verified treatment failures with cefixime and ceftriaxone were also reported from Europe. In the European Union\/European Economic Area (EU\/EEA), the European gonococcal antimicrobial surveillance programme (Euro-GASP) funded by the ECDC is running. In 2011, the Euro-GASP included 21\/31 (68%) EU\/EEA countries, and the programme is further strengthened annually. However, in the non-EU\/EEA countries, internationally reported and quality assured gonococcal AMR data are lacking in 87% of the countries and, worryingly, appropriate support for establishment of a GASP is still lacking. Accordingly, national and international support, including political and financial commitment, for gonococcal AMR surveillance in the non-EU\/EEA countries of the WHO European Region is essential.<\/jats:p>","DOI":"10.1136\/sextrans-2012-050909","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T14:33:46Z","timestamp":1384526026000},"page":"iv42-iv46","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union"],"prefix":"10.1136","volume":"89","author":[{"given":"Magnus","family":"Unemo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A","family":"Ison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Spiteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marita","family":"van de Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lali","family":"Khotenashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"2024051410040603000_89.Suppl_4.iv42.1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.63"},{"key":"2024051410040603000_89.Suppl_4.iv42.2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.690396"},{"key":"2024051410040603000_89.Suppl_4.iv42.3","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.042648"},{"key":"2024051410040603000_89.Suppl_4.iv42.4","doi-asserted-by":"crossref","unstructured":"Cole MJ Unemo M Hoffmann S . The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill 2011;16 :pii=19995.","DOI":"10.2807\/ese.16.42.19995-en"},{"key":"2024051410040603000_89.Suppl_4.iv42.5","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.12.117"},{"key":"2024051410040603000_89.Suppl_4.iv42.6","doi-asserted-by":"crossref","unstructured":"Van de Laar M Spiteri G . Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe. Euro Surveill 2012;17 :pii=20225.","DOI":"10.2807\/ese.17.29.20225-en"},{"key":"2024051410040603000_89.Suppl_4.iv42.7","doi-asserted-by":"crossref","first-page":"p11=19792","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"2024051410040603000_89.Suppl_4.iv42.8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"2024051410040603000_89.Suppl_4.iv42.9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"2024051410040603000_89.Suppl_4.iv42.10","doi-asserted-by":"crossref","first-page":"pii=19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"2024051410040603000_89.Suppl_4.iv42.11","doi-asserted-by":"crossref","first-page":"pii=19833","DOI":"10.2807\/ese.16.14.19833-en","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill"},{"key":"2024051410040603000_89.Suppl_4.iv42.12","doi-asserted-by":"crossref","first-page":"pii=19998","DOI":"10.2807\/ese.16.43.19998-en","article-title":"First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"2024051410040603000_89.Suppl_4.iv42.13","doi-asserted-by":"crossref","first-page":"pii=20200","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill"},{"key":"2024051410040603000_89.Suppl_4.iv42.14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt034"},{"key":"2024051410040603000_89.Suppl_4.iv42.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.176575"},{"key":"2024051410040603000_89.Suppl_4.iv42.16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment of gonorrhea","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2024051410040603000_89.Suppl_4.iv42.17","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks162"},{"key":"2024051410040603000_89.Suppl_4.iv42.18","unstructured":"World Health Organization (WHO). Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae . Geneva: WHO, 2012:1\u201336. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501 (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.19","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050674"},{"key":"2024051410040603000_89.Suppl_4.iv42.20","unstructured":"European Centre for Disease Prevention and Control (ECDC). Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. Stockholm: ECDC, 2012:1\u201323. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.21","unstructured":"Centers for Disease Control and Prevention (CDC). Cephalosporin-resistant Neisseria gonorrhoeae public health response plan. 2012:1\u201343. http:\/\/www.cdc.gov\/std\/gonorrhea\/default.htm (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.22","unstructured":"World Health Organization (WHO). Prevalence and incidence of selected sexually transmitted infections: Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis . Methods and results used by WHO to generate 2005 estimates. Geneva: World Health Organization, 2011. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241502450\/en\/ (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.23","unstructured":"World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections\u20142008. Geneva: World Health Organization, 2012. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/2008_STI_estimates.pdf (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.24","unstructured":"European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe, 1990\u20132010. Stockholm: ECDC, 2012. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/201206-Sexually-Transmitted-Infections-Europe-2010.pdf (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.25","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.042317"},{"key":"2024051410040603000_89.Suppl_4.iv42.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2011.02780.x"},{"key":"2024051410040603000_89.Suppl_4.iv42.27","unstructured":"GRASP Steering Group. The gonococcal resistance to antimicrobials programme (GRASP) year 2010 report. London: Health Protection Agency, 2011. http:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1316016752917 (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.28","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.026021"},{"key":"2024051410040603000_89.Suppl_4.iv42.29","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.029033"},{"key":"2024051410040603000_89.Suppl_4.iv42.30","doi-asserted-by":"crossref","first-page":"pii=19533","DOI":"10.2807\/ese.15.14.19533-en","article-title":"The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)\u2013national resistance prevalence in 2007 and 2008, and trends during 2005\u20132008","volume":"15","author":"Kubanova","year":"2010","journal-title":"Euro Surveill"},{"key":"2024051410040603000_89.Suppl_4.iv42.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2011.02770.x"},{"key":"2024051410040603000_89.Suppl_4.iv42.32","unstructured":"World Health Organization and UNAIDS. Strategies and laboratory methods for strengthening surveillance of sexually transmitted infection 2012. Appendix 3. Geneva, Switzerland: World Health Organization, 2012. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241504478\/en\/index.html (accessed 15 Aug 2013)."},{"key":"2024051410040603000_89.Suppl_4.iv42.33","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.044164"},{"key":"2024051410040603000_89.Suppl_4.iv42.34","doi-asserted-by":"crossref","unstructured":"Chisholm SA Unemo M Quaye N . Molecular epidemiological typing within the European gonococcal antimicrobial resistance surveillance programme reveals predominance of a multidrug-resistant clone. Euro Surveill 2013;18 :pii=20358.","DOI":"10.2807\/ese.18.03.20358-en"},{"key":"2024051410040603000_89.Suppl_4.iv42.35","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq476"},{"key":"2024051410040603000_89.Suppl_4.iv42.36","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp098"},{"key":"2024051410040603000_89.Suppl_4.iv42.37","doi-asserted-by":"crossref","unstructured":"Frigo N Unemo M Kubanova A . Russian gonococcal susceptibility programme (RU-GASP)\u2014resistance levels in 2010 and trends during 2005\u20132010. Poster P1.S1.42 presented at the 19th biennial conference of the International Society for sexually transmitted diseases Research. Qu\u00e9bec City, Canada , 10\u201313 July 2011.","DOI":"10.1136\/sextrans-2011-050108.42"},{"key":"2024051410040603000_89.Suppl_4.iv42.38","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.009051"},{"key":"2024051410040603000_89.Suppl_4.iv42.39","first-page":"65","article-title":"Guidelines for laboratory diagnosis of Neisseria gonorrhoeae in East-European countries. Part 1: Gonorrhoea, sampling, and microscopy for diagnosis","volume":"14","author":"Savicheva","year":"2007","journal-title":"Acta Medica Lituanica"},{"key":"2024051410040603000_89.Suppl_4.iv42.40","first-page":"123","article-title":"Guidelines for laboratory diagnosis of Neisseria gonorrhoeae in East-European countries. Part 2: culture, non-culture methods, determination of antibiotic resistance, and quality assurance","volume":"14","author":"Savicheva","year":"2007","journal-title":"Acta Medica Lituanica"},{"key":"2024051410040603000_89.Suppl_4.iv42.41","first-page":"E071206.3","article-title":"Guidelines for laboratory diagnosis of Neisseria gonorrhoeae infections in Eastern European countries\u2014results of an international collaboration","volume":"12","author":"Domeika","year":"2007","journal-title":"Euro Surveill"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2012-050909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:41:10Z","timestamp":1746045670000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2012-050909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":41,"journal-issue":{"issue":"Suppl 4","published-online":{"date-parts":[[2013,11,15]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/sextrans-2012-050909"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2012-050909","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}